Cooper University Hospital

Cooper University Hospital

group_cooperContact Information

  Cooper University Hospital
Three Cooper Plaza, Suite 215
Camden, New Jersey 08103

  Andrew March (856) 342-2460


arc300x79 300x79 2care300x79crest300x79

Site Coordinator

Christine Rickette
Phone: (856) 342-3024

Site Investigators

colcher_cooperAmy Colcher, MD

Amy Colcher, MD has recently joined Cooper University Hospital to become Director of the Cooper Neurological Institute Movement Disorders division. Dr. Colcher comes to Cooper after 15 years at the University of Pennsylvania where she was Clinical Associate Professor of Neurology. She completed a fel- lowship in Movement disorders at the University of Pennsylvania after her Neurology training at Georgetown University. She earned her medical degree from Jefferson Medical College. Dr. Colcher is a well-known authority in movement disorders. She has authored numerous articles and chapters.

A Diplomate of the American Board of Psychiatry and Neurology, Dr. Colcher serves on the board of the Eastern Pennsylvania chapter of the Huntington’s Disease Society of America. She is involved in Clinical research and conducts trials on Huntington’s disease, Parkinson’s disease, and other movement disorders. She treats patients with dystonia, and has expertise in the use of Botulinum toxins. She sees patients with Parkinson’s disease, Multiple system atrophy, Progressive Supranuclear Palsy, essential tremor, Ataxia, and Huntington’s disease and other movement disorders.


McGarry_ cooperAndrew McGarry, MD

Andrew McGarry, MD is an alumnus of UMDNJ and Cooper Hospital for medical school clerkships and completed neurology residency at the University of Rochester. He subsequently completed a fellowship in movement disorders and experimental therapeutics at Rochester. He is board certified in neurology and belongs to the American Academy of Neurology, Alpha Omega Alpha Medical Society, and the Movement Disorder Society.

Dr. McGarry’s interests include Parkinson Disease, Huntington’s Disease, spinocerebellar ataxias, and Friedreich’s Ataxia. His clinical involvement includes delivery of botulinum toxin, deep brain stimulation management, resident education, and medical treatment of tremor, chorea, dystonia, tics, and myoclonus of varying etiologies. Dr, McGarry has interest in the development and implementation of clinical trials in movement disorders.